LCLuís Fernando Ferreira Cavalcante

Luís Fernando Ferreira Cavalcante

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luís Fernando Ferreira Cavalcante has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The effect of tranexamic acid in perioperative bleeding transfusion in radical cystectomy: a systematic review and meta-analysis

    by Pedro Faria Makabe, Luís Fernando Ferreira Cavalcante, Bruno Yuamoto, Sophia Massafelli Battistuta, Giovanna Ristori Costa, Luís Guilherme Giacon Meloni, Felipe Endrigo Gonçalves Vilela, Isadora Silva Fanucci Bueno, Roni de Carvalho Fernandes, Luis Gustavo Morato de Toledo

    Tranexamic acid (TXA) is an antifibrinolytic agent with demonstrated benefits in various surgical procedures, including urological surgeries. However, its


  • Open Access

    Critical Analysis of the Clinical and Lipidic Profile of Patients with Acute Coronary Syndrome in a Public Hospital in São Paulo

    by Giovanna Ristori Costa, Luís Fernando Ferreira Cavalcante, Renato Jorge Alves

    Background: Myocardial infarction (MI) is highly influenced by risk factors such as dyslipidemia. Achieving low-density lipoprotein cholesterol (LDL-C) goals is key to reducing the residual cardiovascular risk. However, the proportion of patients with MI who accomplish this goal is unknown. Objective: Assess risk factors, lipid profile evolution from admission to the first outpatient consultation, and the therapy administered. Methods: This is a descriptive study of patient charts from a public hospital in São Paulo from June 2021 to March [...] Abstract Background: Myocardial infarction (MI) is highly influenced by risk factors such as dyslipidemia. Achieving low-density lipoprotein cholesterol (LDL-C) goals is key to reducing the residual cardiovascular risk. However, the proportion of patients with MI who accomplish this goal is unknown. Objective: Assess risk factors, lipid profile evolution from admission to the first outpatient consultation, and the therapy administered. Methods: This is a descriptive study of patient charts from a public hospital in São Paulo from June 2021 to March

  • Open Access

    Operative Versus Nonoperative Management of Penetrating Liver Injuries: A Systematic Review and Meta-analysis

    by Sophia Massafelli Battistuta, Luís Fernando Ferreira Cavalcante, Giovanna Ristori Costa, Pedro Faria Makabe, Bruno Yuamoto, Rafael DE Oliveira Bento, Pedro DE Souza Lucarelli Antunes, Luca Giovanni Antonio Pivetta, Jose Cesar Assef

    Introduction: While the conservative management of blunt liver injuries is well established in the medical literature, with reported success rates ranging from 82% to 100% in hemodynamically stable patients, its application to penetrating injuries remains controversial due to perceived risks. This study aims to assess the potential outcomes of non-operative management (NOM) in selected patients with penetrating liver injuries compared to operative management (OM). Methods: A systematic review and meta-analysis of observational studies comparing NOM and OM in patients with penetrating liver injuries was conducted using the Medline, Scopus, and Cochrane databases, in accordance with the Cochrane Handbook for Systematic Reviews of Interventions and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Results: Six observational studies comprising 4,407 patients were included. NOM was associated with lower mortality (RR 0.40; 95% CI 0.31-0.53; I2=0%; p<0.01) and complication rates (RR 0.83; 95% CI 0.75-0.91; I2=0%; p<0.01). No statistically significant difference was observed in liver complications (RR 0.25; 95% CI 0.01-12.47; I2=0%; p=0.10), blood transfusion (RR 0.73; 95% CI 0.0-1741.82; I2=84%; p=0.73), and hospital length of stay (RR -0.44; 95% CI -6.76-5.87; I2=0%; p=0.83). Conclusion: Non-operative management of penetrating liver injuries, when compared to operative management, may be considered a possible alternative for selected patients.

  • Open Access

    Tratamento Operatório Versus Não Operatório de Lesões Penetrantes de Fígado: Uma Revisão Sistemática e Meta-análise

    by Sophia Massafelli Battistuta, Luís Fernando Ferreira Cavalcante, Giovanna Ristori Costa, Pedro Faria Makabe, Bruno Yuamoto, Rafael DE Oliveira Bento, Pedro DE Souza Lucarelli Antunes, Luca Giovanni Antonio Pivetta, Jose Cesar Assef

    RESUMO Introdução: Embora o tratamento conservador de lesões hepáticas contusas esteja bem estabelecido na literatura médica, com taxas de sucesso relatadas variando de 82% a 100% em pacientes hemodinamicamente estáveis, sua aplicação em lesões penetrantes permanece controversa devido às potenciais complicações. Este estudo tem como objetivo avaliar os desfechos do tratamento não operatório (TNO) em pacientes selecionados com lesões hepáticas penetrantes, em comparação ao tratamento operatório (TO). Métodos: Uma revisão sistemática e meta-análise de estudos observacionais comparando TNO e TO em pacientes com lesões hepáticas penetrantes foi conduzida por meio dos bancos de dados Pubmed, Scopus e Cochrane de acordo com o Guia Cochrane para Revisões Sistemáticas e Meta-análises e Itens de Relato Preferenciais para Revisões Sistemáticas e Meta-Análises (PRISMA). Resultados: Foram abordados seis estudos observacionais que incluíram 4.407 pacientes. O TNO foi associado a menor mortalidade (RR 0.40; 95% CI 0.31-0.53; I2=0%; p<0.01) e menores taxas de complicação (RR 0.83; 95% CI 0.75-0.91; I2=0%; p<0.01). Não foi observada diferença estatisticamente significativa nas taxas de complicações hepáticas (RR 0.25; 95% CI 0.01-12.47; I2=0%; p=0.10), nas taxas de transfusão sanguínea (RR 0.73; 95% CI 0.0-1741.82; I2=84%; p=0.73) e na duração da internação hospitalar (RR -0.44; 95% CI -6.76-5.87; I2=0%; p=0.83). Conclusão: O TNO de lesões hepáticas penetrantes, quando comparado ao TO, pode ser considerado uma alternativa possível para pacientes selecionados.

  • Antimicrobial Envelopes for Cardiac Device Infection Prevention: A Meta‐Analysis of Randomized and Matched Studies

    by Alonzo Armani Prata, Luís Fernando Ferreira Cavalcante, Gabriela Blanco Stutz, Thalia Melamed, Caio Rezende Lima, Andrew H. Locke, Alexandra Régia Dantas Brígido

    Introduction: Cardiac implantable electronic device (CIED)‐associated infections are a significant procedural complication. Antibacterial envelopes have emerged as a potential strategy to mitigate this risk, though the evidence regarding their prognostic benefit remains inconclusive. Objectives: We performed a meta‐analysis of randomized controlled trials (RCTs) and propensity score–matched cohorts evaluating the efficacy of the adjunctive use of antimicrobial envelopes in preventing CIED‐related infections compared to standard prophylactic measures alone. Methods: We searched through PubMed, Cochrane, and Embase databases. Our primary outcomes were (1) any CIED‐related infection and (2) major CIED‐related infection. We conducted a sensitivity analysis in high‐risk patients. Results: A total of one RCT and eight observational studies were included, involving 78,587 patients, of whom 12,290 (15.6%) received antimicrobial envelopes. The overall risk ratio (RR) analysis showed no significant difference in the incidence of any CIED‐related infections between the antimicrobial envelope and standard prophylaxis groups (RR 0.55; 95% CI 0.30–1.01; I 2 = 75%). However, time‐to‐event analysis demonstrated that the use of antimicrobial envelopes was associated with a significantly lower risk of any CIED‐related infection [hazard ratio (HR) 0.38; 95% CI 0.17–0.87; I 2 = 67%] and major CIED‐related infection (HR 0.54; 95% CI 0.39–0.76; I 2 = 0%). Moreover, among high‐risk patients, envelope implantation significantly reduced infection risk (RR 0.64; 95% CI 0.47–0.88; I 2 = 22%). Conclusion: Our analysis demonstrates that antibacterial envelopes significantly reduce the risk of CIED‐related infections, particularly in high‐risk patients. Although the additional cost remains a consideration, the time‐to‐event findings and benefit observed in selected high‐risk populations may support their use in appropriately stratified patients.

  • The Effect of GLP-1RA on the Motor Function of Patients With Parkinson Disease

    by Giovanna Ristori Costa, Luís Fernando Ferreira Cavalcante, Sophia Massafelli Battistuta, Pedro Faria Makabe, Isadora Silva Fanucci Bueno, Bruno Yuamoto, Felipe Endrigo Gonçalves Vilela, Luís Guilherme Giacon Meloni, Danilo Donizete de Faria, Renato Anghinah, et al.


  • The Impact of Thyroid Hormones on Brain-Dead Organ Donors: A Systematic Review and Meta-Analysis

    by Luís Fernando Ferreira Cavalcante, Alonzo Armani Prata, Caio Rezende Lima, Gabriela Blanco Stutz, Thalia Melamed, Paulo Ricardo Gessolo Lins, Alexandra Régia Dantas Brígido

  • Open Access

    Surgical management for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome: a systematic review and meta-analysis

    by Luís Fernando Ferreira Cavalcante, Giovanna Costa, Sophia Massafelli Battistuta, Pedro Faria Makabe, Isadora Silva Fanucci Bueno, Bruno Yuamoto, Felipe Endrigo Gonçalves Vilela, Marco Aurélio Palazzi Sáfadi


  • Open Access

    2. Myval versus Contemporary Valves in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis

    by Zeeshan Mansuri, Gokul Rajith, Thahsin Taikadan, Hadiah Ashraf, Ayesha Ayesha, Luis Fernando Ferreira Cavalcante

    The Anatolian Journal of Cardiology - Peer-reviewed cardiology journal publishing original research, reviews, case reports. Impact Factor 1.5. The Anatolian Journal of Cardiology - Leading international cardiology journal with Impact Factor 1.5. Publishing original research, reviews, and case reports in cardiovascular medicine. Indexed in PubMed, Scopus, and Web of Science.